PTC Therapeutics, Inc. (NASDAQ:PTCT) Director Jerome B. Zeldis Sells 20,000 Shares of Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) Director Jerome B. Zeldis sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 22nd. The stock was sold at an average price of $38.24, for a total transaction of $764,800.00. Following the transaction, the director now owns 14,500 shares of the […]
More Stories
Patron Partners LLC Purchases 41 Shares of Mastercard Incorporated (NYSE:MA)
Patron Partners LLC lifted its position in shares of Mastercard Incorporated (NYSE:MA – Free Report) by 0.9% during the 2nd...
Eli Lilly and Company (NYSE:LLY) Shares Bought by Northwest Wealth Management LLC
Northwest Wealth Management LLC boosted its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 1.5% in the...
Chicago Capital LLC Raises Stake in Eli Lilly and Company (NYSE:LLY)
Chicago Capital LLC boosted its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 0.2% during the 2nd...
Wormhole Price Tops $0.19 on Major Exchanges (W)
Wormhole (W) traded 1.6% higher against the U.S. dollar during the one day period ending at 19:00 PM ET on...
Decentralized Social Reaches Self Reported Market Capitalization of $65.08 Million (DESO)
Decentralized Social (DESO) traded up 3% against the dollar during the 1-day period ending at 19:00 PM Eastern on September...
NXM (NXM) Trading Down 0.1% Over Last 7 Days
NXM (NXM) traded flat against the dollar during the 24 hour period ending at 19:00 PM E.T. on September 7th....